Literature DB >> 33914266

Letter to the Editor Regarding Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort Study.

Rajesh Naidu Janapala1, Jigar Patel2, Omar Belfaqeeh2, Abdulla Alhashmi2, Ali Pourmand2.   

Abstract

Entities:  

Keywords:  COVID-19; Mortality benefit; Steroids; Tocilizumab

Year:  2021        PMID： 33914266      PMCID： PMC8083090          DOI： 10.1007/s40121-021-00443-5

Source DB:  PubMed          Journal:  Infect Dis Ther        ISSN： 2193-6382


× No keyword cloud information.
  1 in total

1.  Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort Study.

Authors:  Belén Ruiz-Antorán; Aránzazu Sancho-López; Ferrán Torres; Víctor Moreno-Torres; Itziar de Pablo-López; Paulina García-López; Francisco Abad-Santos; Clara M Rosso-Fernández; Ana Aldea-Perona; Eva Montané; Ruth M Aparicio-Hernández; Roser Llop-Rius; Consuelo Pedrós; Paloma Gijón; Carolina Hernández-Carballo; María J Pedrosa-Martínez; Consuelo Rodríguez-Jiménez; Guillermo Prada-Ramallal; Lourdes Cabrera-García; Josefa A Aguilar-García; Rocío Sanjuan-Jimenez; Evelyn I Ortiz-Barraza; Enrique Sánchez-Chica; Ana Fernández-Cruz
Journal:  Infect Dis Ther       Date:  2020-12-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.